ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,065.20
-0.08%
S&P 500
5,303.27
0.12%
US Dollar vs CAD
1.36175
0.02%
Bitcoin
66,735.45
2.29%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Vaxart Inc (VXRT)

  7. Vaxart Inc (VXRT) News

VXRT

Vaxart (VXRT)

Vaxart Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VXRT
DateTimeSourceHeadlineSymbolCompany
05/13/20243:11PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VXRTVaxart Inc
05/13/20243:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
05/13/20243:01PMGlobeNewswire Inc.Vaxart Provides Business Update and Reports First Quarter 2024 Financial ResultsNASDAQ:VXRTVaxart Inc
05/13/20246:10AMIH Market NewsU.S. Futures Climb Amid High Expectations for Inflation Data; Global Markets Show Mixed ReactionsNASDAQ:VXRTVaxart Inc
05/07/20247:00AMGlobeNewswire Inc.Vaxart to Host First Quarter 2024 Business Update and Financial Results Conference Call on May 13NASDAQ:VXRTVaxart Inc
04/30/20247:00AMGlobeNewswire Inc.Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating MothersNASDAQ:VXRTVaxart Inc
03/27/20247:00AMGlobeNewswire Inc.Vaxart to Present at World Vaccine Congress Washington 2024 on April 3NASDAQ:VXRTVaxart Inc
03/20/20247:00AMGlobeNewswire Inc.Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VXRTVaxart Inc
03/14/20243:01PMGlobeNewswire Inc.Vaxart Provides Business Update and Reports Full Year 2023 Financial ResultsNASDAQ:VXRTVaxart Inc
03/14/20246:41AMIH Market NewsU.S. Stock Futures Rise Ahead Of PPI and Retail Sales; Oil Prices ClimbNASDAQ:VXRTVaxart Inc
03/07/20247:00AMGlobeNewswire Inc.Vaxart to Host Full Year 2023 Business Update and Financial Results Conference Call on March 14NASDAQ:VXRTVaxart Inc
03/06/20248:23AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
03/06/20247:00AMGlobeNewswire Inc.Vaxart, Inc. Appoints Steven Lo as President, Chief Executive Officer, and DirectorNASDAQ:VXRTVaxart Inc
02/29/20243:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
02/15/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
02/13/20244:16PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VXRTVaxart Inc
02/05/20247:00AMGlobeNewswire Inc.Vaxart Announces Publication in Vaccines of Non-Human Primate Preclinical Data Demonstrating Its Next-Generation Vaccine Candidates Elicit Mucosal and Systemic Immunogenicity and Reduce Viral Shedding after SARS-CoV-2 ChallengeNASDAQ:VXRTVaxart Inc
02/02/20243:49PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:VXRTVaxart Inc
01/19/20244:14PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
01/19/20243:30PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:VXRTVaxart Inc
01/19/20247:30AMGlobeNewswire Inc.Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b Clinical Study Evaluating Its COVID-19 Oral Pill Vaccine CandidateNASDAQ:VXRTVaxart Inc
01/16/20244:18PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
01/16/20248:25AMGlobeNewswire Inc.Vaxart Announces $10.0 Million Registered Direct Offering with RA Capital ManagementNASDAQ:VXRTVaxart Inc
01/16/20248:22AMGlobeNewswire Inc.Vaxart, Inc. Announces Management ChangeNASDAQ:VXRTVaxart Inc
01/16/20248:19AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
12/21/20237:00AMGlobeNewswire Inc.Vaxart Announces Last Subject Dosed in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating MothersNASDAQ:VXRTVaxart Inc
11/02/20233:16PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VXRTVaxart Inc
11/02/20233:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VXRTVaxart Inc
11/02/20233:01PMGlobeNewswire Inc.Vaxart Provides Business Update and Reports Third Quarter 2023 Financial ResultsNASDAQ:VXRTVaxart Inc
11/02/20237:00AMGlobeNewswire Inc.Vaxart Doses First Subject in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating MothersNASDAQ:VXRTVaxart Inc
 Showing the most relevant articles for your search:NASDAQ:VXRT

Your Recent History

GATE
KNIGHTUSDT
Forest Knight
FX
TMTUSD
TMT vs US Dollar
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved